Spacer

EQS-News: Wolford AG: 2022 Half-Year Figures: Strategy Meets Sales Expectations

Retrieved on: 
Friday, September 23, 2022
Saskatchewan River Sturgeon Management Board, City, Alberta Ferretti, Madison Avenue, EBIT, Growth, Social media, GCDS, Wolford, EMEA, Paper, Spacer, Awareness, Security (finance), Marketing, Visibility

With sales of 54.3 million for the reporting period from January to June 2022, Wolford recorded an improvement of 29.4% compared to the first half of 2021.

Key Points: 
  • With sales of 54.3 million for the reporting period from January to June 2022, Wolford recorded an improvement of 29.4% compared to the first half of 2021.
  • The sales growth is spread across almost all geographical regions and distribution channels.
  • Following the significant sales growth achieved in the first half of 2022, the Management Board is confident that Wolford will stabilize the positive sales trend in the second half of the year.
  • Wolford is on course in its quest to beat the previous years sales in 2022 despite the still difficult market conditions.

Spacer Technologies Acquires WhereiPark to Scale the Sharing Economy

Retrieved on: 
Wednesday, May 11, 2022
Commercial Building & Real Estate, Technology, Construction & Property, REIT, Software, Internet, Transportation, Lodging, Residential Building & Real Estate, Travel, WagJag, WIP, Technology, Â, AvalonBay Communities, Group, Brookfield Properties, Marriage, Software as a service, CEO, Trailer Park, Inc., B2B, Acquisition, Retail, Self storage, Greystar Real Estate Partners, Spacer

The WhereiPark acquisition is the latest step in Spacers expansion into the North American market, said Spacer CEO, Mike Rosenbaum.

Key Points: 
  • The WhereiPark acquisition is the latest step in Spacers expansion into the North American market, said Spacer CEO, Mike Rosenbaum.
  • It will add significant scale and provide a footprint into new markets, new partnerships, new products and leverage the strengths of each company.
  • The group will be led by DealDirect co-founder and Group CEO Mike Rosenbaum and WhereiPark and WagJag founder Jeremy Zuker.
  • This is the perfect marriage of two popular sharing economies, says Jeremy Zuker, CEO of WhereiPark.

Camber Spine Receives FDA Clearance for SPIRA-P and SPIRA-T Technologies

Retrieved on: 
Tuesday, August 3, 2021
FDA, Health, Surgery, Medical devices, Surgery, Medical specialties, Surgical specialties, Spinal fusion, Spacer, Spira, Neurosurgery

Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.

Key Points: 
  • Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.
  • The SPIRA-T Oblique Posterior Lumbar Spacer features the same qualities, but is designed specifically to accommodate traditional or insert and rotate TLIF procedures.
  • Innovative spine and medical technology company Camber Spine Technologies is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology.
  • Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, Camber Spine is making quantum leaps in the spinal fusion market.

Orthofix Announces U.S. Launch and First Patient Implant of 3D-Printed FORZA Titanium PLIF Spacer System with Nanovate Technology

Retrieved on: 
Tuesday, June 29, 2021
Biotechnology, Health, Surgery, Medical devices, Forza, Chemistry, Physical sciences, Matter, Spacer, PLIF, Asthma spacer, Titanium, Construx

(NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. launch and first patient implant of the FORZA Ti PLIF Spacer System .

Key Points: 
  • (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. launch and first patient implant of the FORZA Ti PLIF Spacer System .
  • View the full release here: https://www.businesswire.com/news/home/20210629005280/en/
    Image of the FORZA Ti Spacer System for PLIF procedures.
  • Features of the FORZA Ti PLIF Spacer System include:
    3D-printed porous titanium with macro, micro, and nanoscale surface features
    The FORZA Ti PLIF Spacer System with Nanovate Technology is available in the U.S. through a targeted commercial release.
  • The FORZA Ti PLIF Spacer System is one of many products that feature Orthofixs Nanovate Technology including the recently launched FORZA TI TLIF Spacer System, CONSTRUX Mini Ti Spacer System, CONSTRUX Mini PTC Spacer System, Pillar SA PTC Spacer System, and the FORZA PTC Spacer System.

ChoiceSpine™ Announces FDA Clearance and Clinical Use of Blackhawk™ Ti Cervical Spacer System

Retrieved on: 
Tuesday, May 25, 2021
FDA, Health, Surgery, Medical devices, Creative works, Comics, Spacer, Blackhawk, Peek, Cervical cap, Adaptation arts)

ChoiceSpine LLC, a privately held spinal device manufacturer based in Knoxville, TN, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk Ti Cervical Spacer System.

Key Points: 
  • ChoiceSpine LLC, a privately held spinal device manufacturer based in Knoxville, TN, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk Ti Cervical Spacer System.
  • View the full release here: https://www.businesswire.com/news/home/20210525005679/en/
    Blackhawk Ti Cervical Spacer System (Photo: Business Wire)
    Anders Cohen, DO, the Lead Design Surgeon for the Blackhawk Ti system, stated, Blackhawk Ti improves and builds upon the already successful original Blackhawk PEEK device with integrated anchor technology.
  • Blackhawk Ti is the first to market 3D-printed system that utilizes preassembled integrated anchor technology.
  • The Blackhawk Ti Cervical Spacer System includes:
    ChoiceSpine LLC, is a spinal device company located in Knoxville, TN and is privately held by Altus Capital Partners.

Life Spine Announces the Completion of the First Surgical Cases With TRULIFT® Expandable Spacer System

Retrieved on: 
Tuesday, May 11, 2021
Medical Supplies, Health, Medical devices, Hospitals, Surgery, Clinical trials, Biotechnology, Spacer, PLIF, XC2, Osseo, Asthma spacer

Use of expandable technology, such as the TRULIFT Expandable Spacer System, has shown a significant reduction in procedure time and improvement in my patient outcomes.

Key Points: 
  • Use of expandable technology, such as the TRULIFT Expandable Spacer System, has shown a significant reduction in procedure time and improvement in my patient outcomes.
  • TRULIFT allows for restoration of anatomical alignment and maintains its length during expansion offering increased endplate coverage,\xe2\x80\x9d said Dr. Richard Weiner of Dallas, TX.\nThe TRULIFT Expandable Spacer System with Osseo-Loc\xc2\xae Surface Technology is the next generation of micro invasive technology for TLIF and PLIF procedures.
  • TRULIFT allows for a generous 6mm of expansion and the implant maintains its proximity to the endplates throughout its entire expansion range.
  • Life Spine, which is privately held, is based in Huntley, Illinois.

Orthofix Announces FDA Clearance and First Patient Implant of the 3D-Printed FORZA Titanium TLIF Spacer System with Nanovate Technology

Retrieved on: 
Thursday, April 22, 2021
Health, FDA, Technology, Surgery, Nanotechnology, General Health, Biotechnology, Spacer, Titanium, Forza, Chemistry, Physical sciences, Matter

(NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration 510(k) clearance and first patient implant of the FORZA\xe2\x84\xa2 Ti TLIF Spacer System .

Key Points: 
  • (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration 510(k) clearance and first patient implant of the FORZA\xe2\x84\xa2 Ti TLIF Spacer System .
  • Developed to help optimize Transforaminal Lumbar Interbody Fusion (TLIF) procedures, the FORZA Ti Spacer with Nanovate\xe2\x84\xa2 Technology is a titanium 3D-printed interbody featuring an optimized design, porosity and surface that allows bone to grow into and through the spacer.
  • View the full release here: https://www.businesswire.com/news/home/20210422005292/en/\nImage of the 3D-printed FORZA Ti Spacer System for TLIF procedures.
  • It will provide access to advanced fusion technology backed by studies that support the proven biological effects of nanoscale features applied to interbody devices.\xe2\x80\x9d\nThe FORZA Ti TLIF Spacer System features include:\n3D-printed porous titanium with macro, micro, and nanoscale surface features\nFeaturing Orthofix\xe2\x80\x99s unique Nanovate Technology, the FORZA Ti TLIF Spacer System is one of many products with nanotechnology FDA clearance including the recently launched CONSTRUX Mini Ti Spacer System, CONSTRUX Mini PTC Spacer System, the Pillar\xe2\x84\xa2 SA PTC Spacer System, and the FORZA\xe2\x84\xa2 PTC Spacer System.

Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology

Retrieved on: 
Monday, April 5, 2021
FDA, Health, Medical devices, Medical specialties, Surgery, Clinical medicine, Anterior cervical discectomy and fusion, Spacer, Construx, Titanium, ACDF, PTC, Discectomy

(NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and the first patient implant of the 3D-printed CONSTRUX Mini Ti Spacer System .

Key Points: 
  • (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and the first patient implant of the 3D-printed CONSTRUX Mini Ti Spacer System .
  • Developed to enhance anterior cervical discectomy and fusion (ACDF) procedures, the CONSTRUX Mini Ti cervical spacer with Nanovate Technology is the first 3D-printed titanium interbody introduced to the market by Orthofix.
  • View the full release here: https://www.businesswire.com/news/home/20210405005029/en/
    Image of Orthofixs first 3D-printed titanium interbody, the CONSTRUX Mini Ti Cervical Spacer System with Nanovate Technology.
  • The CONSTRUX Mini Ti Spacer System with Nanovate Technology is one of many Orthofix products with nanotechnology FDA clearance including the CONSTRUX Mini PTC Spacer System, the Pillar SA PTC Spacer System, and the FORZA PTC Spacer System.

Additive Orthopaedics® Announces New Patient Educational Website www.TotalTalusReplacement.com

Retrieved on: 
Wednesday, March 10, 2021
Musculoskeletal system, Medical Subject Headings, Medical classification, Emerging technologies, Industrial design, Industrial processes, Skeletal system, Talus bone, Talus, Ankle, Spacer, Implant

LITTLE SILVER, N.J., March 10, 2021 /PRNewswire/ --Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces the launch of a new educational website focused on the Patient Specific Talus Spacer.

Key Points: 
  • LITTLE SILVER, N.J., March 10, 2021 /PRNewswire/ --Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces the launch of a new educational website focused on the Patient Specific Talus Spacer.
  • Additive Orthopaedics received an approval order in February 2021 from the U.S. Food and Drug Administration ("FDA") for its Humanitarian Device Exemption application for the Patient Specific Talus Spacer for treatment of AVN of the talus.
  • The approval order made the Additive Orthopaedics Patient Specific Talus Spacer the first and only patient specific total talus replacement implant approved by the FDA for use in the United States.
  • The Patient Specific Talus Spacer is an additively manufactured, or 3D printed, patient specific implant that is designed and made individually for each patient using CT image data.

Additive Orthopaedics® Announces FDA Approval of Patient Specific Talus Spacer, First Approved in the U.S.

Retrieved on: 
Wednesday, February 17, 2021
Musculoskeletal system, Medical Subject Headings, Medical classification, Prosthetics, Biomedical engineering, Spacer, Talus bone, Talus, Implant, Ankle

The approval order makes the Additive Orthopaedics Patient Specific Talus Spacer the first and only patient specific total talus replacement implant approved by the FDA for use in the United States.

Key Points: 
  • The approval order makes the Additive Orthopaedics Patient Specific Talus Spacer the first and only patient specific total talus replacement implant approved by the FDA for use in the United States.
  • The Patient Specific Talus Spacer is indicated for Avascular Necrosis ("AVN") of the ankle joint.
  • The Patient Specific Talus Spacer is an additively manufactured, or 3D printed, patient specific implant that is designed and made individually for each patient using CT image data.
  • The Patient Specific Talus Spacer is another example of how 3D printed devices can improve the standard of care.